EMCURE - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.6

📉 Current Price: ₹1,325

📊 RSI: 44.1 (Neutral to weak zone)

📉 MACD: -9.41 (Bearish momentum)

📉 DMA 50 / 200: ₹1,356 / ₹1,310 (Price between averages)

📉 Volume: 99,895 vs 1Wk Avg 1,54,116 (Below average)

💰 Market Cap: ₹25,122 Cr

📉 Qtr Profit Decline: ₹140 Cr → ₹125 Cr

📈 FII Holding: +0.43%

📈 DII Holding: +1.52%

📌 Optimal Entry Price

🎯 Entry Range: ₹1,300–₹1,320 (Near 200 DMA and RSI base)

📤 Exit Strategy

💡 Exit if: Price approaches ₹1,400–₹1,420 or RSI crosses 65 with weakening volume.

✅ Positive

• Price near 200 DMA offers tactical entry
• Strong institutional interest (FII +0.43%, DII +1.52%)
• EPS of ₹21.1 and low debt-to-equity ratio (0.28)
• ROCE (13.5%) and ROE (11.6%) show decent capital efficiency

⚠️ Limitation

• MACD shows bearish momentum
• Volume below average, indicating weak participation
• High P/E (62.5) vs industry average (33.1)
• Negative PEG ratio (-4.61) suggests valuation concerns

📰 Company Negative News

• Quarterly PAT declined from ₹140 Cr to ₹125 Cr
• MACD and RSI indicate weak short-term momentum

📈 Company Positive News

• Strong increase in DII holding (+1.52%)
• Qtr Profit Var shows 210% YoY growth despite sequential dip

🏭 Industry

• Industry P/E: 33.1 (much lower than EMCURE’s P/E)
• Pharmaceutical sector benefits from global demand and regulatory tailwinds

🔚 Conclusion

EMCURE offers a tactical swing trade opportunity with solid fundamentals and institutional support, though technical indicators are weak. Entry near ₹1,300–₹1,320 is favorable, with an exit target around ₹1,400–₹1,420. A stop-loss below ₹1,280 is recommended to manage downside risk.

I can also monitor RSI and MACD trends for EMCURE to help you catch the next momentum shift.